Accelerate investments in rare and orphan diseases to serve the broader mission of making patient lives better

A decision model for preclinical and clinical stage investments to help unleash the full treatment and commercialization potential in rare and orphan diseases.  RareValue is a robust and repeatable analytic tool for the 7,000 rare and orphan diseases that represent different risk/reward dynamics.

This interactive tool assesses the potential of molecules while enabling filtering by therapy type (e.g. gene therapy, cell therapy) and considering regional differences. Contact us for more information.